Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01591421
Title P13Kinase Inhibitor BKM120 in Combination With Panitumumab in Patients With Metastatic or Advanced RAS-Wild Type Colorectal Cancer.
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors NCIC Clinical Trials Group
Indications

colorectal cancer

Therapies

Buparlisib + Panitumumab

Age Groups: adult
Covered Countries CAN


No variant requirements are available.